Recent progress and considerations for AAV gene therapies targeting the central nervous system

Journal of Neurodevelopmental Disorders
Erik Allen LykkenSteven James Gray

Abstract

Neurodevelopmental disorders, as a class of diseases, have been particularly difficult to treat even when the underlying cause(s), such as genetic alterations, are understood. What treatments do exist are generally not curative and instead seek to improve quality of life for affected individuals. The advent of gene therapy via gene replacement offers the potential for transformative therapies to slow or even stop disease progression for current patients and perhaps minimize or prevent the appearance of symptoms in future patients. This review focuses on adeno-associated virus (AAV) gene therapies for diseases of the central nervous system. An overview of advances in AAV vector design for therapy is provided, along with a description of current strategies to develop AAV vectors with tailored tropism. Next, progress towards treatment of neurodegenerative diseases is presented at both the pre-clinical and clinical stages, focusing on a few select diseases to highlight broad categories of therapeutic parameters. Special considerations for more challenging cases are then discussed in addition to the immunological aspects of gene therapy. With the promising clinical trial results that have been observed for the latest AAV gene therap...Continue Reading

References

Apr 1, 1983·Developmental Medicine and Child Neurology·A Statz, K Felgenhauer
Apr 7, 1998·Immunity·M K SlifkaR Ahmed
Jan 9, 1999·Journal of Virology·J A ChioriniR M Kotin
Jan 12, 1999·Nature Medicine·C SummerfordR J Samulski
Jul 23, 2002·Journal of Virology·Mihail Y MastakovMatthew J During
Jul 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Qing XieMichael S Chapman
Jun 5, 2003·Acta Crystallographica. Section D, Biological Crystallography·Qing XieMichael S Chapman
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Pia KivisäkkRichard M Ransohoff
Sep 23, 2003·Gene Therapy·Charles H ViteJohn H Wolfe
Sep 23, 2003·Nature Medicine·Giovanni Di PasqualeJohn A Chiorini
Sep 8, 2004·Human Molecular Genetics·Ann L CollinsHuda Y Zoghbi
Dec 15, 2004·Journal of Virology·Yuji KashiwakuraHiroyuki Daida
Mar 30, 2005·Journal of Virology·Eric PadronMavis Agbandje-McKenna
Jan 18, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Cassia N Cearley, John H Wolfe
Jan 24, 2006·Nature Biotechnology·Narendra MaheshriDavid V Schaffer
Feb 9, 2006·Nature Biotechnology·Aravind Asokan, R Jude Samulski
Mar 3, 2006·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Michael DiMattiaMavis Agbandje-McKenna
Mar 15, 2006·The Journal of Gene Medicine·S W J McPheeP Leone
Mar 9, 2007·Human Gene Therapy·Jean-Marc TaymansVeerle Baekelandt
Mar 21, 2007·Nature Medicine·Federico MingozziKatherine A High
Aug 31, 2007·Journal of Virology·Hyun-Joo NamMavis Agbandje-McKenna
Oct 10, 2007·American Journal of Human Genetics·Baodong SunDwight D Koeberl
Oct 24, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Samuel L MurphyKatherine High
Mar 14, 2008·Combinatorial Chemistry & High Throughput Screening·Luca PeraboHildegard Büning
May 27, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Wuping LiRichard J Samulski
Aug 21, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Cassia N CearleyJohn H Wolfe
Aug 30, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·James T KoerberDavid V Schaffer
Nov 11, 2008·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Qing XieMichael S Chapman
Dec 23, 2008·Nature Biotechnology·Kevin D FoustBrian K Kaspar
Jan 13, 2009·The Journal of Infectious Diseases·Roberto CalcedoJames M Wilson

❮ Previous
Next ❯

Citations

Apr 14, 2019·The Journal of Gene Medicine·Shanshan Wang, Rongqin Huang
Feb 7, 2020·Expert Opinion on Drug Delivery·Smrithi PadmakumarMansoor M Amiji
May 18, 2020·International Journal of Molecular Sciences·Matthew PiechnikShunji Tomatsu
Jul 9, 2020·Medicinal Research Reviews·Maria Zakharova
Aug 7, 2020·American Journal of Physiology. Gastrointestinal and Liver Physiology·Anthony C JohnsonBeverley Greenwood-Van Meerveld
Apr 22, 2020·Nature Methods·Sripriya Ravindra KumarViviana Gradinaru
Jun 26, 2020·Molecular Biotechnology·Zhixi LiuHongtao Xiao
Aug 17, 2020·Nature Reviews. Neurology·Sarah J TabriziEdward J Wild
Sep 4, 2020·Journal of Neurochemistry·Thomas J TurnerGabriele Lignani
Sep 12, 2019·Frontiers in Neuroscience·Christine SaleebaSimon McMullan
Feb 7, 2020·International Journal of Molecular Sciences·Anna M ChiarellaNathaniel A Hathaway
Jan 28, 2021·Cancer Cell International·Xin XuXiaochun Zhang
Nov 17, 2020·Frontiers in Neuroscience·Fábio Duarte, Nicole Déglon
Feb 21, 2021·Journal of Pharmacological and Toxicological Methods·Joachim MaxeinerJaya Krishnan
Mar 2, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kyung-Won ParkJoanna L Jankowsky
Aug 19, 2020·Journal of Neuroscience Methods·Ayumu Konno, Hirokazu Hirai
May 1, 2021·International Journal of Molecular Sciences·Ana Rita GomesMaria Margarida Diogo
Apr 7, 2021·Human Molecular Genetics·Samantha DeRosaYulia Grishchuk
Jun 2, 2021·Virology Journal·Sepideh SaebChristian Schwartz
Jun 8, 2021·Frontiers in Neural Circuits·Daniel EskenaziNao Chuhma
Jul 25, 2021·Revue neurologique·S MitraB A Minassian
Aug 20, 2021·Life Science Alliance·Cristin D DavidsonWilliam J Pavan
Aug 21, 2021·Essays in Biochemistry·Eva Medico-SalsenchTahsin Stefan Barakat
Aug 22, 2021·Journal of Cellular and Molecular Medicine·Kissaou T TchedreSamarendra K Mohanty
Aug 25, 2021·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Laura SkukanSrećko Gajović
Feb 15, 2020·Molecular Therapy. Methods & Clinical Development·Annabelle SchlüterDaniela Mauceri
Oct 6, 2021·Nature Medicine·Gretchen ThomsenKevin D Foust
Oct 12, 2021·Frontiers in Neuroscience·Jonathan M Fischell, Paul S Fishman
Oct 9, 2021·Journal of Neurosurgery. Pediatrics·Claudia L CravenDominic N P Thompson

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry

Software Mentioned

GENCODE

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Related Papers

Translational Research : the Journal of Laboratory and Clinical Medicine
Michelle E McClements, Robert E MacLaren
Advances in Genetics
Boris KantorSteven James Gray
© 2022 Meta ULC. All rights reserved